Cargando…
Epidemiology of Infections in Cancer Patients
Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk fact...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120867/ https://www.ncbi.nlm.nih.gov/pubmed/24706221 http://dx.doi.org/10.1007/978-3-319-04220-6_2 |
_version_ | 1783515072253919232 |
---|---|
author | Zembower, Teresa R. |
author_facet | Zembower, Teresa R. |
author_sort | Zembower, Teresa R. |
collection | PubMed |
description | Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk factors that predispose to infection and of commonly encountered pathogens is necessary. In addition, clinicians must keep abreast of the changing epidemiology of infections in this population. As therapeutic modalities continue to evolve, as established pathogens become increasingly drug resistant, and as new pathogens are discovered, successful management of infections will continue to present challenges in the years to come. |
format | Online Article Text |
id | pubmed-7120867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71208672020-04-06 Epidemiology of Infections in Cancer Patients Zembower, Teresa R. Infectious Complications in Cancer Patients Article Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk factors that predispose to infection and of commonly encountered pathogens is necessary. In addition, clinicians must keep abreast of the changing epidemiology of infections in this population. As therapeutic modalities continue to evolve, as established pathogens become increasingly drug resistant, and as new pathogens are discovered, successful management of infections will continue to present challenges in the years to come. 2014-04-06 /pmc/articles/PMC7120867/ /pubmed/24706221 http://dx.doi.org/10.1007/978-3-319-04220-6_2 Text en © Springer International Publishing Switzerland 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Zembower, Teresa R. Epidemiology of Infections in Cancer Patients |
title | Epidemiology of Infections in Cancer Patients |
title_full | Epidemiology of Infections in Cancer Patients |
title_fullStr | Epidemiology of Infections in Cancer Patients |
title_full_unstemmed | Epidemiology of Infections in Cancer Patients |
title_short | Epidemiology of Infections in Cancer Patients |
title_sort | epidemiology of infections in cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120867/ https://www.ncbi.nlm.nih.gov/pubmed/24706221 http://dx.doi.org/10.1007/978-3-319-04220-6_2 |
work_keys_str_mv | AT zembowerteresar epidemiologyofinfectionsincancerpatients |